Subcellular Hsp70 Inhibitors Promote Cancer Cell Death via Different Mechanisms

Sang-Hyun Park1, Kyung-Hwa Baek1, Insu Shin1

  • 1Center for Biofunctional Molecules, Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.

Cell Chemical Biology
|July 31, 2018
PubMed

Insights

Cancer cell death mechanisms were clarified using Hsp70 inhibitors. Apoptozole targets lysosomes, while Az-TPP-O3 targets mitochondria, both inducing apoptosis through distinct pathways.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Heat shock proteins (Hsp70) play roles in cancer cell survival.
  • Targeting Hsp70 at different subcellular locations may offer novel cancer therapy strategies.

Purpose of the Study:

  • To elucidate the distinct mechanisms of cancer cell death induced by Hsp70 inhibitors.
  • To investigate the role of subcellular localization in the efficacy of cancer therapeutics.

Main Methods:

  • Utilized apoptozole (Az), an Hsp70 inhibitor, and its conjugate Az-TPP-O3.
  • Examined subcellular localization (lysosomes vs. mitochondria) in cancer cells.
  • Assessed effects on lysosomal and mitochondrial membrane permeabilization and autophagy.

Main Results:

  • Apoptozole (Az) induced lysosomal membrane permeabilization and impaired autophagy.
  • Az-triphenylphosphonium conjugate (Az-TPP-O3) inhibited mortalin-p53 interaction and induced mitochondrial outer membrane permeabilization, without affecting autophagy.
  • Both compounds effectively promoted cancer cell death via distinct apoptotic pathways.

Conclusions:

  • Inhibitors of lysosomal Hsp70 and mitochondrial mortalin induce cancer cell death through different mechanisms.
  • Understanding the subcellular targets and functions of small molecules is crucial for deciphering their mode of action and therapeutic potential.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K